Research Council Announcements: Grants

Grants announcements from the MassGeneral Hospital for Children Research Council.


Applications are now being accepted by the Executive Committee on Research (ECOR) for the Tosteson & Fund for Medical Discovery (FMD) Postdoctoral Fellowship Awards!

What is it? The Tosteson & FMD Awards are intended to support junior investigators (MD and PhD fellows/postdocs) at Massachusetts General Hospital pursuing either basic or clinical research.

The ECOR Subcommittee on Review of Research Proposals (SRRP) reviews the applications and selects the awardees. The top three applicants will receive Tosteson Awards - named for the longtime Dean of the Harvard Faculty of Medicine - and the remaining awardees receive FMD awards.

How much is each award? The awards are $40,000 for up to one year, plus applicable fringe benefits and 15% indirect costs.

When is the deadline? Tuesday, April 22, 2014 – 9:00 PM

How do I learn more and apply? Click here to read more and apply online!

Visit the ECOR website and specifically the Tosteson and Fund for Medical Discovery under the Awards and Grants tab of the site.


Call for Pilot Feasibility Project applications in Nutrition, Obesity or related research fields (new and competing renewals). Deadline: May 15th, 2014

The Nutrition Obesity Research Center at Harvard (NORC-H, previously known as the Harvard Clinical Nutrition Research Center) will be accepting applications for new pilot feasibility projects as well as for competing renewals of currently funded 1-year projects for the 19th year of the NIH-supported NORC. Projects will be funded up to $20,000 in the first year with the possibility of a second year.

The specific purpose is to find:

1. Young investigators (senior fellows* or junior faculty) established by research programs relevant to clinical research who are without NIH R01 and R21 grant support (K awardees are encouraged to apply).

2. Established scientists not currently focused on nutrition per se who wish to initiate studies of direct or indirect importance to nutrition, metabolism or obesity.

3. Established nutrition researchers with novel new projects distinctly removed from their currently funded projects.

Applications should be in the format of an R01, including all the NIH forms and budget pages, with the text portion of the grant limited to 3-5 pages single-spaced (NIH PHS398). For anyone planning to submit a continuation, please be certain to detail the progress you have made in the first year, as well as your plans for the proposed second year.

In addition, please suggest 3 or 4 individuals who might be able to review your application knowledgeably. These individuals can be from within or outside the NORC-H, but should not be current collaborators. Please include their full names, mailing addresses, telephone and fax numbers, and e-mail addresses.

All applications should be received in the NORC-H office by May 15, 2014. Please submit electronically to Ewelinka ‘Nika’ Grzejka at For a complete application go to the NORC-H web-site

For any science related questions, please contact Dr. Steven Grinspoon, Co-Director of the NORC-H and Director of the Pilot Feasibility Program at 617-724-9109.

*Fellows must be in the final year of training and must have a documented commitment to a faculty appointment by a sponsoring division or department.


MGH-MIT RFA: Transforming Diagnosis.

Investigators and research leadership at MGH and MIT have been working for the past year to establish an MIT-MGH Strategic Partnership. The first Grand Challenge in this partnership is entitled Transforming Diagnostics and has been the subject of two workshops to date. Based on discussions at these workshops and in other venues, on behalf of co-chairs Charlie Sodini and David Louis, the MIT-MGH Strategic Partnership is pleased to announce the new RFA and call for proposals.


MGH-MIT Strategic Partnership Grand Challenge 1: Diagnostics
Make diagnosis cost-effective and accurate, and guide individual clinical decisions based on real-time monitoring and massive patient data sets.


Award Types and Amounts:

  • 2 (two) “large” grants at $150,000 (total costs) per team per year for up to 2 years
  • 4 (four) "small" at $50,000 (total costs) per team per year for 1 year
  • 3 (three) “continuation" projects at $50,000 (total costs) per team for 1 year, to follow a "small" project

Letter of Intent: E-mail notification is required by May 15, 2014 if you plan on submitting a proposal. Letters of intent should include the names of the principal investigators and a brief description of the project. Write to: AND to


Full Proposal Submission Date: June 16, 2014

Project Start Date: September 1, 2014

Submission Information: Letters of intent and applications should be submitted electronically to: AND to

To learn more about the MGH-MIT Strategic Partnership and to view the complete RFA, please click here.


The Broad Medical Research Program (BMRP) at the Crohn’s and Colitis Foundation of America (CCFA)

In January 2014, the BMRP merged with the CCFA to become the BMRP at CCFA. The goals and philosophy of the program remain intact and nothing has changed except for the management. We remain committed to encouraging clinically relevant novel early stage research. The review process and the commitment to rapid decision making and funding have not changed. We are eagerly accepting new letters of intent consistent with the guidelines of the program. Both the Broad Foundation and the CCFA understand the importance of funding pilot clinically relevant research and are committed to doing so until cures are found.

Apply for a grant here.


Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include: 1. Name of the Principal Investigator with appropriate contact information 2. A descriptive title of the potential application 3. Brief description of the project 4. Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities  Please click here for more information and for our internal deadlines.

  • Charles H. Hood Foundation Major Grants Initiative to Advance Child Health
  • Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
  • Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
  • Team-Based Design in Biomedical Engineering Education (R25) - NEW!
  • The NEI Mentored Clinical Scientist Development Program Award (K12) – NEW!
  • NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (R25) - NEW!
  • Collaborative Pediatric Critical Care Research Network (UG1)
  • Data Coordinating Center for the Collaborative Pediatric Critical Care Research Network (U01)
  • Diabetes Research Centers (P30)
  • Consortium for Food Allergy Research (U19)
  • Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32)
  • Edward Mallinckrodt Jr. Foundation Grant
  • Cystic Fibrosis Research and Translation Core Center (P30)
  • American Diabetes Association Pathway to Stop Diabetes Research Awards
  • Atopic Dermatitis Research Network (ADRN) (U19)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471. ______________________________________________________________________

Congressionally Directed Medical Research Programs (CDMRP)

The Fiscal Year 2014 (FY14) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).

This e-mail is to notify the research community of the recently released pre-announcements ( from the following programs:

  • Bone Marrow Failure Research Program (BMFRP) 
  • Neurofibromatosis Research Program (NFRP)
  • Multiple Sclerosis Research Program (MSRP)
  • Ovarian Cancer Research Program (OCRP)
  • Peer Reviewed Cancer Research Program (PRCRP)
  • Peer Reviewed Medical Research Program (PRMRP)

 Tuberous Sclerosis Complex Research Program (TSCRP)

Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement.FY14 pre-announcements can be found in the CDMRP home page features at


NFRP at  






Subsequent notifications will be sent when the program announcements/funding opportunities are released.

New for 2014 - CDMRP’s New Application Receipt System (eBRAP)

For FY14, CDMRP has replaced eReceipt with the electronic Biomedical Research Application Portal (eBRAP). As in the past, application submission is a two-step process requiring both (1) pre-application submission through the eBRAP ( and (2) application submission through (, with application status available on eBRAP.

A key feature of eBRAP is that organizational representatives and PIs will be able to view and modify the application submissions associated with them, but only if their organization, Business Officials, and PIs are registered and affiliated to their organization in eBRAP.

Submission of either the pre-application to eBRAP or the application to does not require registering an organization and affiliating its Business Officials and PIs in eBRAP; however, the ability to view and modify the application in eBRAP is contingent upon this registration and affiliation process.


Private Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

  • Antonio Champalimaud Vision Award, Champalimaud Foundation
  • 2014 Shields Award, Child Neurology Foundation
  • Edward H. Schuchman Research Fellowship, National Niemann-Pick Disease Foundation
  • Alton Ochsner Research Scholarship, American Association for Thoracic Surgery

Institutional Research Training Grants, Society for Academic Emergency Medicine Foundation

Please click here for further details on these funding opportunities.


AGA-Pfizer Research Award

Are you interested in studying the role of Janus kinase (JAK) pathways in the pathophysiology and immunology of IBD? Pfizer, Inc., in cooperation with the AGA Research Foundation, is offering up to $100,000 per year for two years (total $200,000) for this research through the new AGA-Pfizer JAK-IBD Research Grant. Unlike other awards from the AGA Research Foundation, there are no geographic or applicant age restrictions to apply. The recipient will be selected based on significance and implications of the research to the treatment of IBD, innovation, approach, the applicant’s research environment and evidence of institutional commitment. Applications must be submitted to both Pfizer, Inc. and the AGA Research Foundation; however a subcommittee of the AGA Research Awards Panel will review all applications and select the recipient. The application deadline is June 6, 2014. More information for this award is available on AGA’s website. Funding for this grant is provided by Pfizer, Inc., New York, NY.


PCORI Funding Opportunities

For latest newsletter from the Patient-Centered Outcomes Research Institute (PCORI), including funding opportunities, click here.


The Boston Biomedical Innovation Center (B-BIC) Launches PILOT and DRIVE Grants

Pre-proposals are now being accepted on a rolling basis. Visit for more information. B-BIC provides support for the development of devices, diagnostics, and therapeutics related to heart, lung, blood, and sleep disorders. PILOT grants provide up to $50,000 for direct costs for 1 year and DRIVE grants provide up to $200,000 for direct costs for milestones achieved over 1½ to 2 years. It’s recommended that you contact your institutional site miner before submission. B-BIC is a consortium of academia, government, venture capital, non-profit, and industry designed to accelerate translational research.


The Harrington Scholar-Innovator Award

The Harrington Scholar-Innovator Award recognizes physician-scientists throughout the U.S. whose research has the potential to change standard of care.

The Award provides inventive physician-scientists the resources to advance their discoveries:

  • An unrestricted award of $100,000
  • Additional funding based on the needs of the project
  • Direct strategic and project management support through our Innovation Support Center


  • Letter of Intent: Friday, May 2, 2014 at 5:00 PM, Eastern Daylight Time (EDT).
  • Full Proposal (for those invited): Friday, August 1, 2014 at 5:00 PM, EDT.

Application Instructions and Policies: For complete list of instructions and to review the grant policies, please visit

For more information on the LOI requirements, please click here.

Questions: Please email or call 216-983-3472.


ALSF Announces New $1.5 Million Bio-Therapeutics Impact Grant

Alex's Lemonade Stand Foundation is excited to offer our new Bio-Therapeutics Impact Grant, totaling a maximum of $1.5 million over three years. This grant will fill a critical funding niche in our research Accelerator Program by empowering investigators to initiate clinical trials for promising and novel biologic approaches to treating childhood cancer.

According to David G. Poplack, MD, PhD, and ALSF Scientific Advisory Board Member, this new grant category is unique because it maximizes recent advances in biomedical research making it possible to develop new treatments that harness a patient's own immune system to fight their cancer or apply new biologically based treatments to target specific childhood cancers.

Please click here to review the guidelines. Deadline: June 12, 2014

Questions? Contact Jenny Filer at or (610) 649-3034.


NIH Funding Opportunities

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link:


What will we discover next?

Learn how researchers at MassGeneral Hospital for Children are finding new treatments that advance pediatric care.